most essential to guard against variation in local standards of collecting data. With this taken care of, it then becomes necessary to programme adequately for computer. We seem to be moving into an era when magnetic discs will be used for recording data and cases will be up-dated daily through a telephone system, thereby enabling ready retrieval of data for sampling or administrative purposes. It should be appreciated here that one is talking of 'hardware' data: age, sex, occupation, education, ethnic origin, and so on -which may be analysed in terms of diagnosis -and not in terms of clinical studies which would require special programming and would not be incorporated in a case register.
Norway has had a national register of all patients admitted to psychiatric hospitals for many years which Odegaard has used to good advantage epidemiologically. A few State registers have been instituted in U.S.A. with, so far, limited success. The aims and methods of one U.K. register in a municipal area, the Camberwell Cumulative Psychiatric Case Register has recently been described (Social Psychiatry, 3, 116), especially its value as a samplingframe and for planning new facilities. The Aberdeen register in U.K. is also well-known. The importance of such a facility to mental health services is that, for those conditions where the administrative prevalence is near the 'community prevalence', the accumulation of cases can lead to the determination of risk dates. In some cases, this would need to be supplemented through data obtained from other resources known to exist in the area. Where there is a well-defined population, census data can be used and all case registers should operate on this basis. Confidentiality, of course, i s essential.
EDITORIAL ANNOTATIONS

MONOAMIN ES AND AFFECTIVE DISORDERS
A fundamental approach to the understanding of affective disorders is provided by the hypothesis that these are due to alterations in brain monoamines. Certainly, many of the drugs that are of value in the treatment of affective disorders influence the storage, release, metabolism or action of the pharmacologically active monoamines that are present in the brain. The main monoamines are noradrenaline, 5-hydroxytryptamine (or serotonin) and dopamine. It has been suggested by Brodie and his colleagues1 that noradrenaline is the modulator of synaptic transmission in a diencephalic system concerned with energy expenditure and the alert state, whereas 5-hydroxytryptamine acts similarly in a diencephalic system controlling energy conservation and sleep. Dopamine, which is largely concentrated in the corpus striatum, is also implicated in affective changes. If the absolute or relative concentrations of these amines are altered by drugs, changes in affective state are noticeable.
At the present time, most research is being concentrated on the role of noradrenaline in the central nervous system as a determinant of mood and behaviour. Noradrenaline in pre-synaptic nerve terminals is stored in granules in a bound form from which it is released by nerve impulses. The released noradrenaline is available for action on post-synaptic receptors and thereby influences the activity of the post-synaptic neurone. The free noradrenaline may be metabolized extracellularly by catechol-0-methyltransferase, or it may be taken up again into pre
